News search

    E.g., 01/12/2024
    E.g., 01/12/2024
    Vicente Andrés, director de investigación básica del CNIC; Dr. Valentín Fuster, director general del CNIC; Dra. del Instituto de Salud Carlos III, Dra. Marina Pollán; Alberto Sanz, director gerente del CNIC; el Dr. Borja Ibáñez, director científico y director de investigación clínica del CNIC; D. Agustín González, subdirector general de redes y centros de investigación cooperativa del Instituto de Salud Carlos III., e Icíar Areilza, secretaria general de la Fundación Pro CNIC.
    About the CNIC
    12 Apr 2024
    Visit of the Director of Carlos III Health Institute, Dr Marina Pollán, to CNIC
    Alberto Pascual
    Research
    11 Apr 2024
    Alberto Pascual: “Wanting to live forever is not the best thing for a species”
    Miembros del equipo del Dr. Miguel Torres.
    About the CNIC
    11 Apr 2024
    The REACTIVA project, led by CNIC scientist Dr. Miguel Torres, receives ERC Advanced Grant funding

    The CNIC project will use innovative approaches to investigate cardiac regeneration

    María Linarejos Vera, Gema Mondéjar, Amaia Talavera, Patricia Sánchez, Álvaro Macías, Juan Manuel Ruiz, Francisco M. Cruz, Fernando Martínez de Benito, Juan Antonio Bernal y José Jalife
    Research
    11 Apr 2024
    Circulation Research: New mechanism discovered for the life-threatening arrhythmias in Andersen-Tawil syndrome

    CNIC researchers, led by Dr. José Jalife, have made a key discovery about cardiac arrhythmias in Andersen-Tawil syndrome (ATS)
    El Dr. Valentín Fuster con la Dra. Guiomar Mendieta
    About the CNIC
    10 Apr 2024
    The Journal of the American College of Cardiology garlands the CNIC author of a PESA-CNIC-SANTANDER study

    Guiomar Mendieta has been awarded the 2023 William W. Parmley Young Author Achievement Award for a paper published in JACC that is considered to an outstanding contribution in the field of atherosclerosis
    Daniel Ruiz Iruela, subdirector de Programas Internacionales de Investigación y Relaciones Institucionales del ISCIII; Laura Redondo, técnica de transferencia de tecnología del CNIC; Gemma Gómez, gestora de transferencia de conocimiento del CIBER-ISCIII; Rubén Nieto y Martín León, responsable de Transferencia y responsable de Innovación de la Plataforma ITEMAS, respectivamente, y Francisco Javier García, responsable de la Oficina de Transferencia del Conocimiento (OTC) del ISCIII,
    About the CNIC
    25 Mar 2024
    CNIC participates in the Foro Transfiere, the main meeting on Science, Technology and Innovation in the south of Europe
    Rodrigo Fernández Jiménez ha sido galardonado con el Premio Nacional de Investigación para Jóvenes ‘Gabriella Morreale’
    About the CNIC
    15 Mar 2024
    Rodrigo Fernández Jiménez, ‘Gabriella Morreale’ National Youth Research Award winner

    The award honours the quality and relevance of his research work in preventive medicine and on current challenges in the field of cardiology
    About the CNIC
    9 Feb 2024
    CNIC Conference Cardiovascular Risk Factors and Brain Health

    The National Center for Cardiovascular Research Carlos III (CNIC) is excited to announce the upcoming edition of the CNIC Conferences
    Carlos Torroja, Jacob F. Bentzon, Paula Nogales, Laura Carramolino, Vanessa Cumbicus, Daniel Morales, Ana Dopazo, Verónica Labrador y Alberto Benguria
    Research
    1 Feb 2024
    Nature Cardiovascular Research: New approach to the design of therapies that enhance the effect of cholesterol-lowering drugs

    A study published in Nature Cardiovascular Research reveals smooth muscle-derived cells as a new target for reducing the size of atherosclerotic plaque. The results open up new avenues for the design of treatments to enhance the beneficial effect of cholesterol-lowering drugs
    Catarina Tristão Pereira, Enrique Lara Pezzi, Raquel Toribio Fernández, Borja Ibáñez, Valentín Fuster, Sergio Callejas, Marta Cortés Canteli, Ana Dopazo, Pilar Martín, Inés García Lunar e Irene Fernández Nueda.
    Research
    23 Jan 2024
    Circulation Research: APOE genetic variants linked to Alzheimer disease are also associated with the development of subclinical aterosclerosis

    The most potent genetic risk factor for Alzheimer disease, APOE4, is associated with an elevated risk of developing subclinical atherosclerosis in middle age, whereas the Alzheimer-protective variant of the same gene, APOE2, protects against subclinical atherosclerosis